Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for NFIX_NFIB
Z-value: 4.70
Motif logo
Transcription factors associated with NFIX_NFIB
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFIX
|
ENSG00000008441.18 | NFIX |
|
NFIB
|
ENSG00000147862.17 | NFIB |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFIB | hg38_v1_chr9_-_14313843_14313985 | 0.68 | 1.6e-05 | Click! |
| NFIX | hg38_v1_chr19_+_12995467_12995500 | 0.49 | 4.4e-03 | Click! |
Activity profile of NFIX_NFIB motif
Sorted Z-values of NFIX_NFIB motif
Network of associatons between targets according to the STRING database.
First level regulatory network of NFIX_NFIB
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 18.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 4.2 | 16.7 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 3.5 | 10.4 | GO:0051041 | positive regulation of calcium-independent cell-cell adhesion(GO:0051041) |
| 3.3 | 3.3 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 2.9 | 8.7 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 2.9 | 8.6 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.5 | 15.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 2.3 | 7.0 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 2.3 | 20.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.2 | 6.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 2.1 | 6.4 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 2.0 | 5.9 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 2.0 | 5.9 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
| 2.0 | 5.9 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 1.9 | 5.8 | GO:0001300 | chronological cell aging(GO:0001300) |
| 1.9 | 9.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.8 | 9.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 1.8 | 12.6 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 1.8 | 5.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 1.8 | 5.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 1.8 | 8.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 1.8 | 14.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 1.7 | 5.2 | GO:0007525 | somatic muscle development(GO:0007525) |
| 1.7 | 1.7 | GO:1905237 | response to cyclosporin A(GO:1905237) |
| 1.7 | 5.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.7 | 6.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.7 | 6.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.7 | 6.7 | GO:1903611 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 1.6 | 1.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.6 | 6.6 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 1.6 | 9.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.6 | 3.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.6 | 4.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 1.6 | 4.8 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 1.6 | 19.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 1.6 | 6.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 1.5 | 6.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 1.5 | 4.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 1.5 | 6.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.5 | 1.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.5 | 4.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 1.5 | 2.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.4 | 11.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 1.4 | 1.4 | GO:0006212 | uracil catabolic process(GO:0006212) |
| 1.4 | 9.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.4 | 12.7 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 1.4 | 8.3 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.4 | 4.1 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 1.3 | 5.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.3 | 5.4 | GO:0044691 | tooth eruption(GO:0044691) |
| 1.3 | 9.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.3 | 5.3 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.3 | 10.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 1.3 | 7.7 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.3 | 3.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.3 | 15.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.2 | 7.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.2 | 3.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.2 | 3.7 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.2 | 2.4 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.2 | 15.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.2 | 7.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.2 | 1.2 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.2 | 3.5 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 1.2 | 4.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.1 | 3.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.1 | 2.3 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 1.1 | 3.4 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.1 | 3.4 | GO:0061027 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 1.1 | 5.6 | GO:1904141 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.1 | 3.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.1 | 9.8 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 1.1 | 4.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 1.1 | 9.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.1 | 9.5 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 1.0 | 7.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
| 1.0 | 4.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 1.0 | 11.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.0 | 4.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 1.0 | 1.0 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 1.0 | 13.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 1.0 | 1.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 1.0 | 4.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 1.0 | 7.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.0 | 17.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.0 | 7.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 1.0 | 5.0 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 1.0 | 6.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.0 | 1.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 1.0 | 20.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.0 | 3.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 1.0 | 3.9 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.0 | 7.6 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.9 | 3.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 2.8 | GO:0003168 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.9 | 3.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.9 | 10.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.9 | 2.8 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.9 | 3.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.9 | 9.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.9 | 2.7 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.9 | 4.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.9 | 4.3 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.9 | 4.3 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
| 0.9 | 3.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.9 | 5.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.9 | 2.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.8 | 1.7 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
| 0.8 | 3.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.8 | 2.5 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.8 | 2.5 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.8 | 3.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.8 | 2.5 | GO:0031104 | dendrite regeneration(GO:0031104) |
| 0.8 | 3.3 | GO:0010193 | response to ozone(GO:0010193) |
| 0.8 | 3.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.8 | 2.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.8 | 9.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.8 | 2.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.8 | 0.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.8 | 1.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.8 | 4.0 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
| 0.8 | 4.0 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.8 | 4.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.8 | 0.8 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.8 | 2.3 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
| 0.8 | 7.7 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.8 | 3.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.7 | 3.0 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.7 | 8.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.7 | 20.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.7 | 2.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.7 | 2.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.7 | 2.2 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.7 | 3.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.7 | 3.6 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.7 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.7 | 51.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.7 | 9.3 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.7 | 4.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.7 | 6.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.7 | 2.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 1.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.7 | 2.8 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 0.7 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.7 | 4.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.7 | 13.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.7 | 8.2 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.7 | 4.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.7 | 11.5 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.7 | 2.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.7 | 4.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.7 | 0.7 | GO:0071657 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.7 | 4.7 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.7 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.7 | 1.3 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.7 | 1.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.7 | 2.6 | GO:0048749 | compound eye development(GO:0048749) |
| 0.7 | 3.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.6 | 3.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 3.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 | 4.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.6 | 8.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.6 | 2.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.6 | 7.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.6 | 2.5 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.6 | 11.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.6 | 2.5 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.6 | 2.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.6 | 3.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.6 | 4.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.6 | 6.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.6 | 1.2 | GO:1903061 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) positive regulation of protein lipidation(GO:1903061) |
| 0.6 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.6 | 4.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.6 | 1.2 | GO:0061055 | myotome development(GO:0061055) |
| 0.6 | 4.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.6 | 4.3 | GO:0046618 | drug export(GO:0046618) |
| 0.6 | 2.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.6 | 5.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.6 | 1.8 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.6 | 10.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.6 | 2.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.6 | 3.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.6 | 3.5 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.6 | 1.2 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.6 | 2.9 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.6 | 2.3 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 0.6 | 8.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.6 | 2.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.6 | 2.8 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 0.6 | 1.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.6 | 1.7 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.6 | 1.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.5 | 19.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 | 0.5 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.5 | 2.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.5 | 9.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.5 | 5.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.5 | 1.6 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.5 | 1.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.5 | 1.6 | GO:0000097 | sulfur amino acid biosynthetic process(GO:0000097) |
| 0.5 | 2.7 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.5 | 4.3 | GO:0001519 | peptide amidation(GO:0001519) peptide modification(GO:0031179) |
| 0.5 | 1.1 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
| 0.5 | 3.7 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.5 | 5.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 | 4.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.5 | 0.5 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.5 | 1.5 | GO:0019089 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.5 | 14.9 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.5 | 4.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.5 | 1.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.5 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.5 | 2.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.5 | 4.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.5 | 0.5 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.5 | 1.5 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.5 | 3.0 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
| 0.5 | 2.0 | GO:1900190 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.5 | 1.5 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
| 0.5 | 1.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.5 | 3.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.5 | 2.0 | GO:0018277 | protein deamination(GO:0018277) |
| 0.5 | 1.0 | GO:0060197 | cloacal septation(GO:0060197) |
| 0.5 | 1.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.5 | 7.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.5 | 2.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.5 | 1.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 | 4.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.5 | 1.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.5 | 3.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.5 | 8.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 | 6.2 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.5 | 0.5 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.5 | 2.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.5 | 1.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.5 | 1.9 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.5 | 1.4 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) guanine catabolic process(GO:0006147) |
| 0.5 | 1.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.5 | 0.9 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.5 | 1.4 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.5 | 10.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.5 | 3.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.5 | 2.8 | GO:0015853 | adenine transport(GO:0015853) |
| 0.5 | 0.9 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.5 | 1.9 | GO:0051801 | cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
| 0.5 | 0.9 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.5 | 1.4 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.5 | 1.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.5 | 9.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.5 | 3.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.5 | 2.8 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 | 5.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 | 1.4 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.5 | 1.4 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.5 | 1.4 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.5 | 1.8 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.5 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.5 | 1.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 | 1.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.4 | 0.4 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.4 | 5.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.4 | 0.9 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.4 | 6.7 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 | 0.4 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.4 | 1.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.4 | 9.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 0.4 | 2.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 1.7 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.4 | 2.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.4 | 1.7 | GO:0042335 | cuticle development(GO:0042335) |
| 0.4 | 2.2 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.4 | 2.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.4 | 9.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.4 | 1.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 2.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 8.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.4 | 1.7 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 0.4 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.4 | 11.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 | 1.7 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.4 | 2.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 | 0.4 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.4 | 1.7 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.4 | 1.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.4 | 1.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 4.2 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.4 | 2.9 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 | 0.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.4 | 2.9 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 1.2 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.4 | 2.9 | GO:0036018 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.4 | 2.0 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.4 | 14.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 1.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.4 | 0.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.4 | 2.4 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.4 | 0.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.4 | 0.8 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.4 | 1.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.4 | 2.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.4 | 5.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.4 | 5.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.4 | 2.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.4 | 3.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.4 | 4.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 | 10.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.4 | 1.6 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.4 | 3.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.4 | 1.2 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.4 | 0.8 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.4 | 0.8 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 0.4 | 4.6 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 1.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.4 | 1.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.4 | 6.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.4 | 1.5 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.4 | 5.2 | GO:0051608 | histamine transport(GO:0051608) |
| 0.4 | 2.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 | 3.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 1.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.4 | 1.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.4 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.4 | 4.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 2.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.4 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.4 | 17.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.4 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 1.4 | GO:0051257 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.4 | 3.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.4 | 2.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.4 | 11.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.4 | 1.8 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.4 | 2.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.4 | 1.1 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.4 | 2.5 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.4 | 3.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 | 0.7 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 9.9 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.4 | 3.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 | 4.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.3 | 1.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.3 | 1.7 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
| 0.3 | 1.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 | 1.7 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.3 | 2.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.3 | 4.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 1.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.3 | 1.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.3 | 1.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.3 | 1.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.3 | 1.4 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
| 0.3 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.3 | 9.5 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
| 0.3 | 4.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.3 | 9.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 1.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 | 1.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.3 | 1.3 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.3 | 1.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.3 | 4.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.3 | 6.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.3 | 0.3 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 0.3 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.3 | 1.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 3.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.3 | 7.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 | 1.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.3 | 8.7 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.3 | 1.0 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.3 | 2.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 1.0 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.3 | 2.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.3 | 0.9 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 | 1.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
| 0.3 | 3.8 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.3 | 0.9 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.3 | 3.1 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.3 | 3.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 | 1.9 | GO:0009624 | response to nematode(GO:0009624) |
| 0.3 | 3.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.3 | 4.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.3 | 2.8 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 | 0.6 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.3 | 6.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 4.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.3 | 0.9 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.3 | 0.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 0.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.3 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 | 3.3 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
| 0.3 | 0.6 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.3 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 1.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.3 | 0.6 | GO:0060003 | copper ion export(GO:0060003) |
| 0.3 | 5.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 | 1.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.3 | 2.9 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 4.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.3 | 3.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.3 | 1.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 2.9 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 | 5.8 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.3 | 0.9 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.3 | 1.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.3 | 4.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 | 1.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 2.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.3 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 | 3.4 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.3 | 2.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.3 | 2.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 | 0.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.3 | 1.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
| 0.3 | 0.6 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.3 | 1.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 | 3.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.3 | 0.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.3 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.3 | 0.8 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.3 | 2.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.3 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 | 1.6 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.3 | 0.8 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.3 | 2.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 0.8 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.3 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 | 2.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.3 | 3.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 1.8 | GO:0015791 | polyol transport(GO:0015791) |
| 0.3 | 1.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.3 | 0.8 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.3 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.3 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.3 | 3.6 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.3 | 5.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.3 | 7.2 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.3 | 1.0 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.3 | 1.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.3 | 1.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.3 | 0.8 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.3 | 2.0 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.3 | 0.8 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.3 | 4.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 | 1.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.3 | 2.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.5 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.3 | 1.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 | 0.8 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 | 2.0 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.3 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 1.5 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.2 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.2 | 0.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.2 | 0.5 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.2 | 2.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 1.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 2.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 0.2 | GO:1903949 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 | 2.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 7.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 0.2 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.2 | 8.5 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.2 | 0.7 | GO:0018194 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 4.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.2 | 1.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 1.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 1.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 2.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 4.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 0.5 | GO:0061047 | regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 0.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 | 1.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.2 | 0.9 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 1.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 0.9 | GO:0051563 | astrocyte activation involved in immune response(GO:0002265) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.2 | 1.4 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 0.5 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.2 | 4.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 1.4 | GO:0045764 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) positive regulation of cellular amino acid metabolic process(GO:0045764) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.2 | 0.7 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.2 | 4.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 3.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.2 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.2 | 0.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 8.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 2.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 1.6 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 | 8.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.2 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 2.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 0.7 | GO:0046713 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.2 | 1.7 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.2 | 1.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.2 | 0.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 0.6 | GO:0031445 | regulation of heterochromatin assembly(GO:0031445) positive regulation of heterochromatin assembly(GO:0031453) positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.2 | 1.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.2 | 8.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.2 | 3.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 0.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 | 2.1 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.2 | 6.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.2 | 1.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 0.8 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.2 | 0.8 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.2 | 4.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.2 | 0.2 | GO:1903891 | regulation of ATF6-mediated unfolded protein response(GO:1903891) |
| 0.2 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 2.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 1.0 | GO:1901545 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.2 | 1.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.2 | 6.1 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.2 | 0.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.2 | 1.6 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 | 2.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 | 0.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 | 3.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.2 | 2.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.2 | 1.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.2 | 0.6 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.2 | 0.6 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.2 | 2.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.2 | 1.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 6.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.2 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 2.0 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 | 0.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.2 | 1.6 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 | 7.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 0.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.2 | 3.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 0.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.2 | 1.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.7 | GO:1990834 | response to odorant(GO:1990834) |
| 0.2 | 0.2 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.2 | 4.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 | 0.6 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 1.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 | 0.6 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 5.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 | 5.3 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 3.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.2 | 2.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.2 | 0.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.2 | 1.3 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 0.5 | GO:0007343 | egg activation(GO:0007343) |
| 0.2 | 0.5 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.2 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 0.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.2 | 7.0 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.2 | 0.2 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.2 | 0.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.2 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 | 0.7 | GO:1903059 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) regulation of protein lipidation(GO:1903059) negative regulation of protein lipidation(GO:1903060) |
| 0.2 | 1.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.2 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 | 1.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 2.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 0.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 | 9.8 | GO:0003341 | cilium movement(GO:0003341) |
| 0.2 | 1.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 2.9 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 | 1.9 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
| 0.2 | 0.5 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.2 | 1.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.2 | 0.2 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.2 | 5.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.2 | 0.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.2 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.2 | 2.8 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.2 | 0.7 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 | 0.7 | GO:0097156 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.2 | 0.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.2 | 2.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.2 | 0.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 | 12.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 1.3 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.2 | 7.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.2 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.2 | 2.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.2 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.2 | 2.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.2 | 1.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 1.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.2 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 3.2 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.2 | 0.6 | GO:0097286 | iron ion import(GO:0097286) |
| 0.2 | 2.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 1.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 2.4 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
| 0.2 | 1.6 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.2 | 5.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.6 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 4.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 0.3 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.2 | 3.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 | 0.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 | 1.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.2 | 1.8 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.2 | 9.0 | GO:1990748 | cellular detoxification(GO:1990748) |
| 0.2 | 2.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 0.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.2 | 1.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 1.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 | 1.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.2 | 1.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 0.5 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 1.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.1 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 3.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 1.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.1 | 2.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 1.6 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 | 4.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 0.1 | GO:2000793 | nephrogenic mesenchyme morphogenesis(GO:0072134) cell proliferation involved in heart valve development(GO:2000793) |
| 0.1 | 1.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 2.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 | 0.3 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.1 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.1 | GO:0046959 | habituation(GO:0046959) |
| 0.1 | 0.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 1.9 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.1 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 6.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.4 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.1 | 0.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 1.5 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 | 1.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.5 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
| 0.1 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 2.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 | 0.4 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 2.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 | 1.7 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 2.0 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.7 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 0.5 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 | 2.1 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 15.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.5 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 1.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 0.4 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 6.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.1 | 0.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 2.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 2.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 1.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.1 | 4.2 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 2.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 | 0.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 | 0.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.1 | 0.6 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 4.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 | 2.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 2.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 1.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.1 | 2.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 0.9 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
| 0.1 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.1 | 4.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.5 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.1 | 2.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 1.5 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.1 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 | 0.4 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 | 2.6 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 2.3 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 3.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 2.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
| 0.1 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 3.3 | GO:0032094 | response to food(GO:0032094) |
| 0.1 | 0.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.3 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.1 | 9.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 | 2.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 4.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 1.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.1 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 3.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 1.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 1.5 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.3 | GO:1904863 | regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 0.1 | 6.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.1 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.1 | 3.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.1 | 5.5 | GO:0019395 | fatty acid oxidation(GO:0019395) |
| 0.1 | 3.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.1 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 2.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.1 | 1.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 7.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 | 0.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.9 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 0.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 2.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.6 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 1.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.1 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.1 | 0.8 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.1 | 0.5 | GO:1902462 | transforming growth factor beta activation(GO:0036363) mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 1.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.1 | 5.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 5.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 0.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 3.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.7 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
| 0.1 | 2.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.1 | 5.4 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.1 | 1.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.9 | GO:0003360 | brainstem development(GO:0003360) |
| 0.1 | 1.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.3 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 0.1 | 1.3 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
| 0.1 | 2.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.1 | 0.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.6 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 0.3 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 0.3 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
| 0.1 | 2.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 1.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
| 0.1 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.3 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.1 | 1.0 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 1.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.9 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.1 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 | 2.2 | GO:0007129 | synapsis(GO:0007129) |
| 0.1 | 0.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 3.2 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 3.9 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 0.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 0.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 1.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 1.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.2 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.1 | 1.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 | 1.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.1 | 0.8 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
| 0.1 | 10.3 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.1 | 0.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.7 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.1 | 1.5 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
| 0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.1 | 0.5 | GO:0046218 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.1 | 0.1 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
| 0.1 | 0.2 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 | 3.5 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 0.9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 2.7 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 1.0 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 40.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.1 | 1.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 | 0.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 0.6 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.1 | 2.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 0.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 2.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.1 | 0.3 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 2.4 | GO:0043090 | amino acid import(GO:0043090) |
| 0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.1 | 0.6 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.1 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.2 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.1 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.1 | 0.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.1 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.1 | 1.1 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.1 | 0.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.6 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.1 | 1.2 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.8 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 2.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.6 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 4.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 | 0.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 | 1.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.2 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.1 | 0.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 | 1.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 1.7 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.3 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 0.1 | 1.7 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.2 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 | 1.5 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.0 | 0.1 | GO:0098504 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.0 | 0.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
| 0.0 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.0 | 0.3 | GO:0090110 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 | 0.5 | GO:0032057 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 | 1.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.0 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.0 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.0 | 0.2 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
| 0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.8 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.0 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 | 1.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.0 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.0 | 0.1 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 1.7 | GO:0090277 | positive regulation of peptide hormone secretion(GO:0090277) |
| 0.0 | 1.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.0 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 | 5.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 | 0.1 | GO:0070512 | negative regulation of histone H3-K4 methylation(GO:0051572) regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.0 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.0 | 0.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 | 0.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 0.0 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.0 | 0.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.0 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.0 | 0.2 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.0 | 0.5 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 | 0.4 | GO:0001832 | blastocyst growth(GO:0001832) |
| 0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 2.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.3 | GO:2000662 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.0 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.0 | 0.2 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
| 0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.0 | 0.9 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
| 0.0 | 0.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.1 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.6 | GO:0090278 | negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 | 0.2 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.0 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 8.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 | 0.2 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.0 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.0 | 0.5 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.0 | 0.0 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
| 0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.8 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.0 | 0.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.0 | 0.0 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.1 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 | 0.8 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
| 0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.2 | GO:0042462 | eye photoreceptor cell differentiation(GO:0001754) eye photoreceptor cell development(GO:0042462) |
| 0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.7 | 11.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 2.8 | 11.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 2.1 | 6.4 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 1.9 | 9.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.9 | 5.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 1.8 | 7.2 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 1.7 | 36.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 1.7 | 5.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.7 | 6.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.4 | 19.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 1.3 | 12.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 1.3 | 3.8 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 1.3 | 26.5 | GO:0005861 | troponin complex(GO:0005861) |
| 1.2 | 6.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 1.2 | 11.7 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.1 | 5.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.1 | 3.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 1.1 | 25.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.0 | 5.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 1.0 | 2.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.9 | 12.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.9 | 2.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.9 | 9.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.9 | 38.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.9 | 17.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.9 | 2.6 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.8 | 5.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.8 | 0.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.8 | 6.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.8 | 6.8 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.8 | 13.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.8 | 27.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.7 | 10.2 | GO:0030478 | actin cap(GO:0030478) |
| 0.7 | 4.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.6 | 31.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.6 | 3.1 | GO:1990393 | 3M complex(GO:1990393) |
| 0.6 | 0.6 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.6 | 7.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.6 | 0.6 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.6 | 6.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.5 | 3.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.5 | 2.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.5 | 25.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.5 | 7.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.5 | 5.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 9.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.5 | 4.5 | GO:0071546 | pi-body(GO:0071546) |
| 0.5 | 2.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.5 | 2.9 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.5 | 1.5 | GO:1990843 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
| 0.5 | 2.4 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.5 | 1.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.5 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.5 | 5.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.5 | 2.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.4 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.4 | 2.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 2.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.4 | 1.5 | GO:0042627 | chylomicron(GO:0042627) |
| 0.4 | 19.3 | GO:0031430 | M band(GO:0031430) |
| 0.4 | 13.1 | GO:0043218 | compact myelin(GO:0043218) |
| 0.4 | 5.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.4 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.4 | 1.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.4 | 3.8 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.4 | 20.1 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.4 | 1.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.4 | 5.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 16.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.3 | 4.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
| 0.3 | 4.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.3 | 1.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.3 | 1.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.3 | 9.7 | GO:0031672 | A band(GO:0031672) |
| 0.3 | 4.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 1.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.3 | 2.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.0 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.3 | 28.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 0.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.3 | 5.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 100.8 | GO:0030017 | sarcomere(GO:0030017) |
| 0.3 | 5.6 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 3.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 2.4 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.3 | 146.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.3 | 4.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.3 | 43.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 1.7 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.3 | 2.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.3 | 1.4 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.3 | 3.1 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.3 | 2.2 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 1.4 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.3 | 3.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.3 | 1.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.3 | 0.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.3 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 1.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 6.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.3 | 9.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.3 | 0.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 1.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.3 | 5.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 1.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 8.4 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
| 0.2 | 8.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 24.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.2 | 1.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.2 | 4.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 6.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 3.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.2 | 4.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 1.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 4.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 18.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 3.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 6.5 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 1.3 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 2.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 2.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.2 | 1.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 0.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 18.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 12.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
| 0.2 | 33.1 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 5.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 0.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.2 | 8.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 1.1 | GO:0000801 | central element(GO:0000801) |
| 0.2 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 0.9 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 0.5 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) integral component of lysosomal membrane(GO:1905103) |
| 0.2 | 2.0 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 7.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 1.8 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 1.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 5.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.2 | 2.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 1.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.2 | 0.5 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.2 | 16.6 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 2.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 1.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.2 | 0.6 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.2 | 1.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.1 | 1.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 1.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.1 | 1.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 0.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.1 | 2.9 | GO:0033643 | host cell part(GO:0033643) |
| 0.1 | 2.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 9.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.9 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 10.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.1 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 1.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 3.0 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 2.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 1.9 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 4.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 0.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 7.8 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 2.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 2.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 2.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 66.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 5.5 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 3.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 25.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 8.4 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.1 | 0.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 5.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 0.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.3 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 1.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.1 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 1.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 1.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 7.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 3.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 13.5 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 3.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 7.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 1.8 | GO:0030286 | dynein complex(GO:0030286) |
| 0.1 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 1.4 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 23.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
| 0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 2.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.5 | GO:0070449 | elongin complex(GO:0070449) |
| 0.0 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.0 | 7.1 | GO:0070160 | occluding junction(GO:0070160) |
| 0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.2 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.0 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 6.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.0 | 3.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) nuclear stress granule(GO:0097165) |
| 0.0 | 0.7 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 8.3 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.0 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.0 | GO:0030892 | mitotic cohesin complex(GO:0030892) |
| 0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.0 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.2 | 16.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 3.5 | 10.4 | GO:0031737 | CX3C chemokine receptor binding(GO:0031737) |
| 3.1 | 15.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 2.8 | 11.0 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 2.7 | 2.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 2.5 | 7.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 2.5 | 7.4 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 2.3 | 13.9 | GO:0030172 | troponin C binding(GO:0030172) |
| 2.1 | 2.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 2.1 | 14.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 2.1 | 12.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 2.1 | 6.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 2.0 | 10.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 2.0 | 5.9 | GO:0036327 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
| 2.0 | 5.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.9 | 9.6 | GO:0070052 | collagen V binding(GO:0070052) |
| 1.9 | 15.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.9 | 5.6 | GO:0035375 | zymogen binding(GO:0035375) |
| 1.7 | 6.9 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 1.7 | 6.7 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 1.7 | 13.2 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.6 | 4.9 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 1.6 | 4.8 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 1.6 | 14.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 1.5 | 4.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.5 | 4.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.4 | 4.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 1.4 | 4.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 1.4 | 4.2 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 1.4 | 8.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 1.3 | 4.0 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.3 | 2.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.3 | 8.9 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 1.3 | 10.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.2 | 1.2 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) indanol dehydrogenase activity(GO:0047718) |
| 1.2 | 7.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.1 | 3.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.1 | 3.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 1.1 | 25.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 1.1 | 4.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.1 | 3.2 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
| 1.1 | 5.3 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 1.0 | 4.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 1.0 | 3.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 1.0 | 4.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 1.0 | 4.0 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 1.0 | 3.0 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.0 | 1.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 1.0 | 13.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 1.0 | 4.9 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 1.0 | 4.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.0 | 2.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 1.0 | 2.9 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 1.0 | 4.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.0 | 2.9 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.9 | 3.7 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.9 | 3.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.9 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.9 | 18.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.9 | 36.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.9 | 3.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.9 | 3.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.9 | 4.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.9 | 1.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.9 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.8 | 2.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.8 | 3.4 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.8 | 3.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.8 | 4.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.8 | 3.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.8 | 6.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.8 | 4.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.8 | 2.4 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.8 | 7.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.8 | 8.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.7 | 3.7 | GO:0070905 | serine binding(GO:0070905) |
| 0.7 | 8.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.7 | 5.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.7 | 4.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.7 | 2.9 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.7 | 5.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.7 | 2.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.7 | 4.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.7 | 2.1 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.7 | 2.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.7 | 4.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.7 | 2.8 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.7 | 6.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.7 | 6.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.7 | 2.7 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.7 | 2.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.7 | 2.0 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.7 | 6.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.6 | 3.9 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.6 | 7.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.6 | 3.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.6 | 3.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.6 | 1.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.6 | 2.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.6 | 8.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.6 | 21.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.6 | 2.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.6 | 12.7 | GO:0019841 | retinol binding(GO:0019841) |
| 0.6 | 7.8 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.6 | 2.4 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.6 | 2.4 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.6 | 2.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.6 | 4.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.6 | 2.9 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
| 0.6 | 1.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.6 | 2.3 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.6 | 1.7 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.6 | 4.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.6 | 2.8 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.5 | 5.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.5 | 10.8 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.5 | 3.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.5 | 7.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.5 | 3.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.5 | 2.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.5 | 5.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.5 | 2.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.5 | 3.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.5 | 0.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.5 | 3.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.5 | 5.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.5 | 5.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.5 | 1.5 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.5 | 3.4 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.5 | 1.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.5 | 2.9 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.5 | 1.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.5 | 11.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 8.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.5 | 12.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.5 | 4.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.5 | 2.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.5 | 1.4 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.5 | 6.5 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.5 | 1.9 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.5 | 2.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.5 | 1.8 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.5 | 10.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.5 | 3.6 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.5 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.5 | 1.8 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.5 | 9.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.5 | 2.3 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.5 | 9.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.5 | 5.0 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.5 | 10.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.4 | 0.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.4 | 0.9 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 3.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.4 | 4.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.4 | 21.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.4 | 3.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.4 | 47.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 1.7 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.4 | 2.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 4.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.4 | 7.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.4 | 1.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.4 | 10.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 7.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.4 | 3.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.4 | 4.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.4 | 1.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 4.9 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.4 | 2.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.4 | 14.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.4 | 6.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.4 | 1.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.4 | 1.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.4 | 3.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.4 | 43.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.4 | 5.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 6.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.4 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.4 | 1.6 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.4 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.4 | 0.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.4 | 1.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.4 | 1.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.4 | 3.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.4 | 3.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 7.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.4 | 4.8 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.4 | 10.0 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 1.8 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.4 | 1.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.4 | 41.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.4 | 1.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.4 | 4.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.4 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 3.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 1.4 | GO:0015375 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
| 0.3 | 1.0 | GO:0070279 | glycine dehydrogenase (decarboxylating) activity(GO:0004375) oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor(GO:0016642) vitamin B6 binding(GO:0070279) pyridoxal binding(GO:0070280) |
| 0.3 | 2.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 2.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.3 | 2.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 7.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.3 | 6.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.3 | 6.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.3 | 1.9 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.3 | 0.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.3 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 4.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 2.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.3 | 4.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 4.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 11.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.3 | 1.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.3 | 1.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.3 | 1.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 0.3 | 1.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 0.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.3 | 4.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.3 | 0.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.3 | 4.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 1.2 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.3 | 1.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.3 | 5.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.3 | 2.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.3 | 8.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.3 | 3.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.3 | 3.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.3 | 0.8 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.3 | 2.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.3 | 2.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.3 | 3.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 7.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 53.3 | GO:0008201 | heparin binding(GO:0008201) |
| 0.3 | 3.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.3 | 1.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.3 | 0.8 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.3 | 1.1 | GO:0030379 | neurotensin receptor activity, non-G-protein coupled(GO:0030379) |
| 0.3 | 0.5 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.3 | 8.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.3 | 0.8 | GO:0015203 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.3 | 0.8 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.3 | 3.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 5.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.3 | 2.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 5.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 2.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.3 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.3 | 1.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.3 | 2.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.3 | 0.8 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 1.0 | GO:0005113 | patched binding(GO:0005113) |
| 0.3 | 1.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.3 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.3 | 1.5 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.3 | 2.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 0.3 | 2.0 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 5.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 4.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 0.7 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.2 | 21.6 | GO:0005518 | collagen binding(GO:0005518) |
| 0.2 | 0.7 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.2 | 1.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 1.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 0.2 | 1.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 1.7 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.2 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 2.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.2 | 2.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.2 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 31.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 3.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 0.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 5.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.2 | 1.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 0.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.2 | 2.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 7.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 1.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.2 | 5.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 0.7 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.2 | 2.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.2 | 0.7 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.2 | 0.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.2 | 2.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 1.8 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.4 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.2 | 4.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 1.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.2 | 0.7 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
| 0.2 | 2.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 0.9 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.2 | 2.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 0.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 0.6 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 3.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 1.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.2 | 2.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 0.6 | GO:0070975 | FHA domain binding(GO:0070975) |
| 0.2 | 1.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 1.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 6.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 3.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.2 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 2.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 0.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 6.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.2 | 1.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 3.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.2 | 0.6 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.2 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 2.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.2 | 6.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 3.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 0.9 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.2 | 1.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.2 | 3.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.2 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.2 | 1.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 2.0 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
| 0.2 | 1.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.7 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 0.5 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.2 | 7.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 5.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.2 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.2 | 0.5 | GO:0004411 | homogentisate 1,2-dioxygenase activity(GO:0004411) |
| 0.2 | 0.5 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.2 | 1.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 1.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.2 | 3.1 | GO:0015250 | water channel activity(GO:0015250) |
| 0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 10.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 3.8 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.2 | 0.5 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.2 | 4.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.2 | 1.0 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.2 | 3.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.2 | 0.5 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.2 | 1.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.2 | 4.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 0.8 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.2 | 1.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.2 | 1.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.2 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 2.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.2 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 5.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.2 | 1.2 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.2 | 23.2 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.2 | 0.5 | GO:0019785 | ISG15-specific protease activity(GO:0019785) |
| 0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.2 | 4.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 0.5 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 0.9 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.1 | 23.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 1.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 9.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 4.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.9 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 4.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 1.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.4 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.1 | 0.3 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 1.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.6 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.1 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.1 | 3.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 1.0 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.1 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 0.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 2.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 2.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 4.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.5 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.1 | 0.5 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.1 | 1.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.4 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
| 0.1 | 1.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 4.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.4 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.1 | 0.2 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.1 | 4.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 0.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 7.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 2.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 0.6 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 1.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 1.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 1.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 0.6 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.1 | 1.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 5.7 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 0.2 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 0.1 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.1 | 5.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 4.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.1 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.1 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 3.1 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 0.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 1.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 1.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 2.3 | GO:0047617 | CoA hydrolase activity(GO:0016289) acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 1.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.1 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 1.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 0.1 | GO:0051379 | beta-adrenergic receptor activity(GO:0004939) epinephrine binding(GO:0051379) norepinephrine binding(GO:0051380) |
| 0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 1.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 3.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.3 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.1 | 0.6 | GO:0052846 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 1.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 2.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 1.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 3.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.1 | 0.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 0.3 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 1.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 0.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.1 | 5.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 4.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
| 0.1 | 0.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.1 | 0.3 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 1.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.2 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.1 | 1.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.1 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
| 0.1 | 0.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.1 | 0.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.1 | 0.9 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 0.3 | GO:0052810 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.1 | 0.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 1.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 2.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 1.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 9.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.1 | 1.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 3.8 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.1 | 1.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 2.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 8.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 4.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.3 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.1 | 1.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.1 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.1 | 0.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.2 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 0.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 0.5 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.3 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.0 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.0 | 0.1 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.0 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.0 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.0 | 0.4 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.0 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.0 | 0.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.0 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.0 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.0 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.0 | 1.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.0 | 9.2 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 0.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.0 | 0.4 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.0 | 0.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.0 | 1.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.6 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.0 | 0.9 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.0 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 2.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 4.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 4.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.0 | 20.1 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 1.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.0 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 3.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 7.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.1 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.0 | 0.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 1.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.0 | 0.6 | GO:0050661 | NADP binding(GO:0050661) |
| 0.0 | 0.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.0 | 0.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.3 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.0 | 0.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.0 | 0.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 13.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.7 | 13.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.6 | 14.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.6 | 199.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.6 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.5 | 45.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 3.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.4 | 14.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 136.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.3 | 26.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.2 | 14.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 2.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 10.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 6.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 16.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 5.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 7.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.2 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 10.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 49.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 12.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 4.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 13.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.1 | 7.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 4.1 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.1 | 8.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 2.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 8.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 9.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 3.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 8.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 3.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 8.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 3.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 5.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 6.9 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 2.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 2.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 2.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 2.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 1.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 5.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 1.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 2.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 3.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 2.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 4.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.0 | 2.6 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 2.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 2.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 2.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 4.6 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 26.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.0 | 13.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.9 | 27.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.8 | 11.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.7 | 13.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.7 | 27.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.7 | 79.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.7 | 12.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.6 | 6.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.6 | 17.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.6 | 11.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 14.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.5 | 9.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.5 | 11.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.5 | 9.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.5 | 39.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.5 | 8.5 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.5 | 14.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.4 | 5.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.4 | 20.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 20.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.4 | 5.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 11.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.4 | 5.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 8.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.3 | 7.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 4.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.3 | 1.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.3 | 0.6 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.3 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.3 | 10.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 27.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.3 | 4.4 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 6.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 7.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 10.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.3 | 7.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 6.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.2 | 6.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.2 | 8.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 2.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.2 | 8.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 3.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 29.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 4.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 40.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 3.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 5.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 7.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 6.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 6.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 3.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 17.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.2 | 0.2 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
| 0.2 | 6.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 10.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 6.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 1.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.2 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.2 | 2.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.2 | 0.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.2 | 4.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.2 | 7.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 5.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 2.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 3.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 8.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 3.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.1 | 2.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 6.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 11.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 5.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 5.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 5.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 9.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 2.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 0.2 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
| 0.1 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.1 | 1.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 3.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 4.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 7.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 4.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 3.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 3.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 10.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 4.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.5 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 2.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 0.8 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 2.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 1.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 1.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 1.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 11.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.0 | 1.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 1.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 1.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.0 | 1.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 1.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 1.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.0 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 1.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 6.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 0.8 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.0 | 0.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 0.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |